Related Experiment Video

Updated: May 22, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer

Zhan Xiao1, Rosa Carrasco, Krista Kinneer

  • 1MedImmune, Gaithersburg, MD, USA. xiaoz@medimmune.com

Cancer Biology & Therapy
|May 5, 2012
PubMed

Insights

EphB4 receptor tyrosine kinase has dual roles in cancer, promoting tumor growth in breast cancer cells while inhibiting endothelial cell proliferation. Its complex signaling impacts cancer therapy strategies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • EphB4, an Eph receptor tyrosine kinase, is known for roles in neuronal guidance and vascular development.
  • The function of EphB4 in cancer remains largely undefined, presenting a complex area of research.

Purpose of the Study:

  • To investigate the dual role of EphB4 in cancer, examining its effects on both cancer cells and endothelial cells.
  • To elucidate the downstream signaling pathways responsible for EphB4's contrasting effects.

Main Methods:

  • Stimulation of EphB4 using its natural ligand, EphrinB2, and a monoclonal antibody.
  • Analysis of the Ras/ERK pathway activation in MCF-7 breast cancer cells and HUVEC endothelial cells.
  • Investigating downstream effectors by reducing p120 RasGAP in HUVEC cells and knocking down PP2A in MCF-7 cells.

Main Results:

  • EphB4 activation inhibited the Ras/ERK pathway in endothelial cells (HUVECs) but activated it in MCF-7 breast cancer cells.
  • EphB4 activation promoted MCF-7 cell growth while inhibiting HUVEC cell proliferation.
  • Functional coupling of EphB4 to p120 RasGAP in HUVECs and PP2A in MCF-7 cells explained the differential pathway activation.

Conclusions:

  • EphB4 exhibits context-dependent roles in cancer, acting as both a tumor promoter and suppressor.
  • The study demonstrates a novel link between Eph receptors and protein phosphatase 2A (PP2A) in activating oncogenic pathways.
  • Targeting EphB4 for cancer therapy presents challenges due to its opposing effects on cancer and endothelial cells.

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...